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Abstract  Hepatocellular  carcinoma  is  the  sixth  most  common  cancer  throughout  the  world.
It  is  almost  exclusively  arterially  vascularized,  unlike  the  vascularization  of  the  liver,  which  has
a  dual  supply  with  a  portal  component  of  75  to  80%  and  an  arterial  component  of  20  to  25%.
The  reference  treatment  for  intermediary  stages  of  the  Barcelona  (B)  classiﬁcation  is  hepatic
artery  chemoembolization.  The  aim  of  chemoembolization  is  to  inject  the  tumor  chemotherapy
into  the  artery  and  then  to  embolize  the  artery  (or  arteries),  which  supply  the  tumor.  For  this,
knowledge  of  the  anatomy  of  the  hepatic  artery  is  essential.  Approximately  55%  of  the  patients
belong  to  the  modal  distribution,  although  numerous  anatomical  variants  exist  and  must  be
recognized.  In  addition,  primarily  non-hepatic  arteries  may  contribute  to  the  vascularization
of  some  hepatocellular  carcinomas.  Furthermore,  new  arterial  supplies  can  be  recruited  by
tumors  after  surgical  or  chemoembolization  treatments.  The  aim  of  this  article  is  to  describe
the  different  arteries,  which  may  vascularize  hepatocellular  carcinomas.  These  arteries  must
be  looked  for,  recognized,  and  reported  by  the  radiologist  on  cross-section  examinations  in  the
pre-treatment  assessment.
© 2013  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Hepatocellular  carcinoma  is  the  sixth  most  common  cancer  throughout  the  world  [1].  It
is  the  third  leading  cause  of  cancer  deaths  in  the  world  after  colorectal  and  lung  cancers
[2].  The  incidence  of  hepatocellular  carcinoma  in  France  increased  by  4.8%  in  men  and  by
3.4%  in  women  during  the  period  from  1980  to  2005  [3].
Hepatocellular  carcinoma  typically  (75  to  80%  of  the  cases)  develops  on  a  background  of
cirrhosis,  although  it  may  also  occur  in  non-cirrhotic  chronic  liver  disease  and  occasionally
in  a  healthy  liver  [4].
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E-mail address: julien.cazejust@sat.aphp.fr (J. Cazejust).
2211-5684/$ — see front matter © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.diii.2013.04.015
2t
p
m
t
E
t
c
o
m
b
t
t
a
s
e
l
c
a
c
c
s
t
t
i
u
v
w
b
r
p
a
T
b
a
H
A
t
r
T
c
r
n
a
w
o
S
o
t
i
M
T
a
o
T
t
t
a
b
g
i
m
a
b
o
p
(
R
T
i
a
t
m
t
b
t
t
a
(
r
L
T
g
e
left lobe  or  the  left  side  of  the  liver,  but  can  vascularize  the
whole liver  in  under  0.5%  of  the  people  [6].  It  is  present  in
approximately 5%  of  the  population  [7].
Figure 1. Arteriography. Catheterization of the common hepatic
artery  showing the common anatomy. CHA = common hepatic8  
The  Barcelona  Clinic  Liver  Cancer  (BCLC)  classiﬁcation
akes account  of  the  tumor  features,  liver  function  and  the
atient’s general  health.  The  BCLC  algorithm  proposes  opti-
al treatment  strategies  based  on  the  different  stages  of
he disease:  its  use  is  currently  recommended  by  the  main
uropean (EASL)  and  American  (AASLD)  learned  societies  for
he treatment  of  patients  suffering  from  hepatocellular  car-
inoma [1].
In the  intermediary  stages,  which  make  up  approximately
ne third  of  the  cases  at  the  time  of  diagnosis,  the  recom-
ended treatment  is  chemoembolization  [1].  This  can  also
e used  as  an  expectant  treatment  pending  liver  transplan-
ation or  surgical  resection.  Chemoembolization  is  based  on
he principle  of  intra-arterial  injection  of  an  antineoplastic
gent, followed  by  occlusion  of  the  artery  or  arteries,  which
upplies the  tumor(s).  Hepatocellular  carcinomas  are  almost
xclusively vascularized  by  the  hepatic  artery,  whereas
iver, which  does  not  contain  tumor,  has  a  dual  theoreti-
al vascularization  (a  portal  component  of  75  to  80%  and  an
rterial component  of  approximately  20  to  25%).  The  aim  of
hemoembolization is  to  produce  tumor  ischemia  and  con-
entrate the  antineoplastic  agent  in  the  tumor,  reducing  its
ystemic toxicity.
In  order  for  the  treatment  to  be  effective,  it  is  essential
hat it  is  injected  into  the  artery  or  arteries,  which  supply
he tumor(s).  These  arteries  must  be  identiﬁed  by  imaging
n the  pre-treatment  assessment.  Firstly,  it  is  essential  to
nderstand the  common  hepatic  arterial  anatomy  and  its
ariants, and  then,  to  identify  any  extra-hepatic  branches
hich have  vascularized  the  tumor,  and  whether  these  have
een recruited  spontaneously  by  the  tumor  or  have  been
ecruited after  treatment  (particularly  surgical  resection  or
revious chemoembolization).
The  aim  of  this  review  is  to  describe  the  different
rteries, which  may  vascularize  hepatocellular  carcinomas.
hese arteries  must  be  looked  for,  recognized  and  reported
y the  radiologist  on  sectional  imaging  in  the  pre-treatment
ssessment and  catheterized  during  chemoembolization.
epatic arterial anatomy
pproximately  55%  of  the  patients  fall  within  the  modal  dis-
ribution. Anatomical  variants  of  the  hepatic  artery  were
eported by  Michelsin  in  1953  after  cadaver  dissections  [5].
his classiﬁcation  was  revisited  by  Hiatt  et  al.  from  surgi-
al liver  ﬁndings  in  1000  patients  [6]  and  then  extended  as  a
esult of  improved  modern  imaging  techniques  [7].  There  are
umerous variants,  particularly  of  the  right  and  left  hepatic
rteries, which  may  be  present  in  isolation  or  associated
ith the  hepatic  artery  per  se.
Hepatocellular  carcinomas  may  be  vascularized  by  one
r more  branches  arising  from  arteries  supplying  the  liver.
elective catheterization  of  the  different  supplying  artery
r arteries  can  target  injection  of  the  treatment  into  the
umor and  achieve  maximum  sparing  of  liver,  which  is  not
nvolved by  the  tumor.odal distribution
he  modal  distribution  of  hepatic  arterial  vascularization  is
 single  hepatic  artery  (the  so-called  proper  hepatic  artery
a
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r  middle  hepatic  artery),  which  supplies  all  of  the  liver.
he celiac  trunk,  which  arises  from  the  anterior  aspect  of
he aorta  at  the  level  of  the  T12  vertebra,  divides  into
hree branches:  the  splenic  artery,  the  left  gastric  artery
nd the  common  hepatic  artery.  The  common  hepatic  artery
ecomes the  proper  hepatic  artery  after  the  origin  of  the
astro-duodenal artery.  The  proper  hepatic  artery  divides
nto the  right  and  left  branches  of  the  hepatic  artery  (Fig.  1).
The  vascular  supply  to  segments  I and  IV  is  variable.  In
ost people,  the  arterial  branches  which  supply  segment  I
rise  from  the  right  and  left  branches  (Fig.  2),  whereas  the
ranch for  segment  IV  usually  arises  from  the  left  branch
f the  hepatic  artery  (in  approximately  50%  of  the  peo-
le) although  it  also  frequently  arises  from  the  right  branch
approximately 40%  of  the  people)  (Fig.  3).
ight hepatic artery
he  right  hepatic  artery  is,  by  deﬁnition,  an  artery  aris-
ng from  the  superior  mesenteric  artery  and  is  present  in
pproximately 12%  of  the  population  [7].  It  is  classically
he ﬁrst  branch  arising  from  the  right  edge  of  the  superior
esenteric artery  (Figs.  4  and  5).  It  usually  passes  behind
he portal  vein  and  should  not  be  confused  with  an  early
ifurcation of  the  hepatic  artery  in  which  the  right  branch  of
he hepatic  artery  arises  from  the  lateral  edge  of  the  celiac
runk before  the  bifurcation  into  the  splenic,  left  gastric
nd common  hepatic  artery,  and  runs  behind  the  portal  vein
Fig. 6).  The  right  hepatic  artery  can  supply  either  just  the
ight side  or  the  entire  liver.
eft hepatic artery
he  left  hepatic  artery  arises  from  the  left  edge  of  the  left
astric artery  and  passes  through  the  Arantius  sulcus  before
ntering the  liver  (Figs.  7  and  8).  It  classically  supplies  thertery,  PHA = proper hepatic artery, CA = cystic artery, GDA = gastro-
uodenal  artery, R Br. PHA = right branch of proper hepatic artery, L
r. PHA = left branch of proper hepatic artery, S IV Br. = segment IV
ranch.
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Figure 2. Vascularization of a segment I hepatocellular carcinoma in a 68-year-old man. Arteriography showing the arterial branches
supplying the nodule, arising from the left branch (white arrows) and right branch (dotted arrows) of the proper hepatic artery. Axial CT
without iodinated contrast enhancement performed a month after chemoembolization, with lipiodol (b) shows lipiodol uptake in the nodule
(*) of segment I (shown by the dashed arrows), with no uptake in the left lobe, segment IV or right lobe of the liver.
Figure 3. Arteriography showing the branch supplying seg-
ment  IV arising from the right branch of the proper hepatic
artery. PHA = proper hepatic artery, CA = cystic artery, GDA = gastro-
duodenal  artery, R Br. PHA = right branch of proper hepatic artery, L
Figure 4. Axial CT with MIP. The right hepatic artery (arrow)
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seen arising  from  the  anterior  aspect  of  the  abdominal  aortaBr. PHA = left branch of the proper hepatic artery, S IV Br. = segment
IV  branch.
Cystic artery
The  cystic  artery  is  classically  the  ﬁrst  branch  arising  from
the right  branch  of  the  hepatic  artery.  In  some  people,  par-
ticularly if  the  hepatocellular  carcinoma  is  located  on  either
side of  the  gall-bladder  fossa  (segments  IV  and  V),  the  cys-
tic artery  may  partially  or  exclusively  vascularize  the  tumor.
The cystic  artery  supplies  9%  of  the  hepatocellular  carcino-
mas, which  are  vascularized  by  extra-hepatic  arteries  [8].
Chemoembolization  of  the  cystic  artery  is  possible  and
has been  described  as  being  safe  and  technically  possible
b
h
hrises from the superior mesenteric artery (dashed arrow) and
asses  behind the portal trunk (dotted arrow): retro-portal course.
n  67%  of  the  cases  in  a  series  of  25  patients  [9].  It  may,
owever, cause  ischemic  cholecystitis  and  for  this  reason
upraselective catheterization  is  recommended  to  preserve
he vascularization  of  the  gall-bladder  [10].
epato-mesenteric (splenic) trunk
 single,  common  trunk  may  be  present  in  under  0.5%  of  the
ases, from  which  the  celiac  trunk  and  mesenteric  artery
rise. This  is  easy  to  recognize  on  sagittal  CT  sections  (even
ithout contrast  enhancement),  as  a  single,  large  artery  isefore dividing  into  four  separate  arteries  (splenic,  common
epatic, left  gastric  and  superior  mesenteric  arteries).  The
epatic artery  arises  from  the  superior  mesenteric  artery
30  J.  Cazejust  et  al.
Figure 5. Selective arteriography of the superior mesenteric
artery. The right hepatic artery (arrow), which is present in approx-
imately  12% of the population, is the ﬁrst branch arising from the
right  edge of the superior mesenteric artery (dashed arrow). This
runs  upwards and to the right, behind the portal vein.
Figure 6. Axial MIP MRI showing the early origin of the right
branch of the hepatic artery. The celiac trunk (dotted arrow) divides
into  the splenic artery (black arrow) and the common hepatic artery
(white  arrow). The right branch of the hepatic artery (dashed arrow)
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Figure 7. Hepatic artery CT angiogram. Coronal MIP reconstruc-
tion  showing a left hepatic artery (LHA) arising from the left gastric
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Trises  early from the right edge of the celiac trunk and there is no
roper  hepatic artery.
hepato-mesenteric  trunk)  in  approximately  0.5%  to  1%  of
he people,  whereas  the  splenic  artery  and  left  gastric  artery
rise above  and  instead  of  the  celiac  trunk  (Fig.  9).  Once
hese variants  have  been  identiﬁed,  endovascular  guiding  is
hen identical  to  that  which  is  performed  with  the  common
epatic artery  and  its  branches.
uodenal pancreatic arcades
emodynamic  changes  may  develop  as  a  result  of  stenosis
r occlusion  of  the  celiac  trunk  due  to  an  arcuate  ligament
r atheromatous  disease.  The  arterial  supply  to  the  liver  is
hen provided  by  the  duodenal  pancreatic  arcades,  which
rise from  the  superior  mesenteric  artery  and  run  to  the
astro-duodenal artery  (in  which  the  ﬂow  is  countercurrent)
nd then  the  proper  hepatic  artery  [11].  Chemoembolization
o
o
r
wrtery  (LGA). SA = splenic artery, SMA = superior mesenteric artery,
DA  = gastro-duodenal artery, PHA = proper hepatic artery.
ay  be  performed  by  catheterizing  these  various  arteries,
sually with  a  microcatheter  (Fig.  10).
xtra-hepatic arteries
lthough  most  hepatocellular  carcinomas  are  vascularized
y the  hepatic  artery  or  its  branches,  they  may  receive  their
rterial supply  from  extra-hepatic  arteries.  Patients  must  be
hecked for  ‘‘parasitic’’  collateral  vascularization  to  ensure
hat chemoembolization  is  both  effective  and  safe  [10].
Several  arteries  close  to  the  liver,  which  are  initially
‘non-hepatic’’ in  destination,  may  be  ‘‘recruited’’  by  the
umor for  its  vascular  supply.  There  are  two  reasons  for
his: the  site  of  the  tumor  (subcapsular,  subdiaphragmatic,
edunculated, etc)  and  some  previous  treatments,  which
ead to  changes  in  tumor  vascularization  (development  of
eovascularization after  surgical  division  of  an  artery,  redis-
ribution of  arterial  ﬂow  after  obstruction  of  some  arteries
y chemoembolization).
Hepatocellular carcinomas  in  contact  with  the  liver  cap-
ule have  an  overall  likelihood  of  17%  of  being  supplied
y extra-hepatic  arteries  [12].  This  likelihood  depends  on
umor size  [13]:  63%  of  tumors  over  6  cm  in  size  and  3%  of
umors under  4  cm  in  size  are  vascularized  by  extra-hepatic
rteries [12].
The main  extra-hepatic  arteries,  which  may  supply
epatocellular carcinomas,  are  the  right  inferior  phrenic,
mental, intercostal,  right  internal  mammary,  right  renal,
drenal and  lumbar  arteries.
ight inferior phrenic artery
he  phrenic  arteries  usually  arise  from  the  aorta  but  may
riginate from  the  celiac  trunk  (in  41%  of  the  cases)  [14],
r more  occasionally  from  the  ipsilateral  renal  artery.  The
ight inferior  phrenic  artery  is  the  main  extra-hepatic  artery,
hich may  supply  hepatocellular  carcinoma  (Fig.  11)  and  is
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Figure 8. 68-year-old male patient with left lobe hepatocellular carcinoma and the left hepatic artery. Selective angiography of the left
hepatic artery (a): the white arrow shows the catheter in the left hepati
of the left hepatic artery, showing uptake in the nodule (black arrow), w
(white arrow) and no lipiodol in the right lobe of the liver (dashed arrow
Figure 9. Selective arteriography showing a hepato-mesenteric
trunk (HMT). The common hepatic artery (CHA) arises from the
superior  mesenteric artery (SMA) before dividing into the gastro-
duodenal  artery (GDA) and its right (R Br. PHA) and left (L Br. PHA)
branches;  whereas the splenic artery (SA) and left gastric artery
(LGA)  arise from a common ‘‘gastro-splenic’’ trunk.
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Figure 10. Coronal abdominal CT with MIP reconstruction (a) and corre
artery (b) showing dilated, tortuous duodeno-pancreatic arcades (dashed 
from the mesenteric artery (MSA) to the gastro-duodenal artery (GDA), b
the proper hepatic artery. CA = celiac trunk.c artery. CT scan (b) a few hours after lipiodol chemoembolization
ith diffuse distribution of lipiodol in the left lobe and segment IV
).
ound  in  up  to  50%  of  the  ‘‘parasitic’’  extra-hepatic  arter-
es [8].  The  right  inferior  phrenic  artery  may,  in  particular,
ascularize hepatocellular  carcinomas  located  in  segment
II [13,15],  the  right  postero-superior  (de-peritonealized)
egion of  the  liver  (area  nuda)  and  also  segment  I  [15].
Chemoembolization  via  the  right  inferior  phrenic  artery  is
enerally well  tolerated  although  right  shoulder  pain,  pleu-
al effusion,  atelectasis  and  diaphragmatic  paralysis  have
een described  [10].
mental arteries
he  omental  arteries  are  the  second  most  common  extra-
epatic arteries,  which  may  vascularize  hepatocellular
arcinoma and  have  been  described  in  15%  of  the  cases  of
xtra-hepatic vascularization  [8].  The  omental  arteries  sup-
ly the  greater  omentum  and  arise  from  the  right  and  left
astro-epiploic arteries,  which  in  turn  arise  from  the  gastro-
uodenal artery  and  the  distal  portion  of  the  splenic  artery.
spondence with selective arteriography of the superior mesenteric
arrow). The liver is vascularized by these arcades, blood circulating
efore entering its right (R Br. PHA) and left (L Br. PHA) branches of
32  J.  Cazejust  et  al.
Figure 11. Axial abdominal CT scan (a) showing several hypervascular nodules of carcinoma in liver segment VII (dashed arrow) and a
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barge diameter right inferior phrenic artery (arrow). Selective arte
ilated vessels (dashed arrows) in the dome of the liver (b).
epatocellular  carcinomas,  which  are  vascularized  by  the
mental arteries,  are  those  in  contact  with  the  surface  of
he liver  [16]  but  because  of  the  mobility  of  the  greater
mentum, they  may  be  found  in  any  region  of  the  surface  of
he liver  (Fig.  12)  [10].
In  a  recent  study,  omental  arteries  supplying  a  hepato-
ellular carcinoma  were  found  to  arise  from  branches  of  the
plenic artery  in  0.6%  of  the  cases  (34/5413  patients).  This
‘parasitic’’ vascularization  was  visible  angiographically  in
5% of  the  cases  and  on  the  pre-embolization  CT  scan  in  79%
f the  cases  [17].
Chemoembolization via  the  omental  arteries  is  described
s being  safe  and  effective.  No  severe  complications  (omen-
al or  gastro-intestinal  ischemia)  were  reported  in  a  series
a
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g
t
igure 12. Celiac trunk arteriography (a) showing several omental art
astric artery (dashed arrow), contributing to the vascular supply of a la
iver. These arteries are visible (arrows) on the axial section MIP abdom
ollowed by right portal embolization before right hepatectomy. Note, co
ranches (after right portal embolization).aphy of the right inferior phrenic artery (arrow) showing tortuous
f  21  patients,  and  overall  survival  was  81%  at  6  months  and
8% at  12  months  [16].  In  the  series  reported  by  Choi  et  al.,
 partial  or  complete  response  was  obtained  in  21  (62%)  of
he 34  patients  treated  [17].
ntercostal arteries
epatocellular  carcinomas  can  be  vascularized  by  the  inter-
ostal  arteries.  These  are  generally  large  hepatocellular
arcinomas in  the  subcapsular  region,  in  contact  with  the
nterior abdominal  wall,  with  or  without  abdominal  wall
nvasion (Fig.  13).  The  intercostal  arteries  responsible  are
enerally hypertrophied  and  arise  from  levels  T8  to  T11  on
he right  [18].
eries arising from the gastro-duodenal artery (arrows) and the left
rge subcapsular hepatocellular carcinoma in the right lobe of the
inal CT scan (b) after a lipiodol chemoembolization ‘‘sequence’’
ils in the branches of the right anterior and posterior portal sector
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Figure 13. 73-year-old man with multifocal hepatocellular carcinoma. The most peripheral carcinoma nodules are partly supplied by
intercostal arteries. Two intercostal arteries are seen on the axial abdominal MRI with MIP reconstruction (a). different areas of lipiodol
uptake (arrows) in the peripheral subcapsular nodules on the abdominal scan without enhancement, after selective chemoembolization of
the intercostal arteries (b).
Figure 14. Axial abdominal CT with MIP reconstruction showing
a  large centro-hepatic hepatocellular carcinoma (dashed arrows).
The  anterior peripheral subcapsular portion is partly vascularized
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aIntercostal  arteries,  supplying  hepatocellular  carcino-
mas, can  be  seen  in  approximately  50%  of  the  people  by
multi-detector CT  compared  to  rotational  scanning  (C-Arm
CT) using  a  ﬂat  sensor  when  angiography  is  performed
[19] and  in  approximately  54%  of  the  cases  compared  to
arteriography [20].  Most  studies  consistently  report  that
visualization of  an  intercostal  artery  on  the  CT  scan  is  an
important diagnostic  feature  of  ‘‘parasitic’’  vascularization
of hepatocellular  carcinoma,  particularly  when  the  diame-
ter of  the  hepatic  artery  is  reduced  [20].
Chemoembolization  is  possible  but  may  cause
complications,  involving  shoulder  pain,  pruritus,  erythema
and skin  necrosis  [18].
Internal mammary artery (or internal thoracic
artery)
The  internal  mammary  artery  can  also  be  recruited  by  hepa-
tocellular carcinomas,  in  approximately  2.3%  of  the  cases
[8]. It  arises  from  the  interior  aspect  of  the  ipsilateral  sub-
clavian artery,  descends  vertically  along  the  anterior  chest
wall and  stems  into  the  phrenic  and  intercostal  branches.
The right  internal  mammary  artery  can  supply  tumors  in
segments VIII  and  IV  of  the  liver  (Fig.  14)  in  hepatocellu-
lar carcinomas  located  on  the  ventral  aspect  of  the  liver
whereas the  left  internal  mammary  artery  can  supply  left
lobe tumors.
In one  study,  38  out  of  the  2815  patients  that  had
chemoembolization,  had  at  east  partial  vascularization  of
their hepatocellular  carcinoma  by  an  internal  mammary
artery on  angiography  (which  is  considered  to  be  the
‘‘reference’’ investigation)  [21].  A  supplying  artery  was  seen
on the  pre-treatment  CT  scan  in  30  of  these  38  patients
(79% of  the  cases).  The  two  criteria  in  this  study  [21]  sup-
porting vascularization  of  a  hepatocellular  carcinoma  by  the
internal mammary  artery  were  a  supplying  artery,  which  was
t
c
o
[rom  the right internal mammary artery (arrow), which is dilated
ompared  to the left internal mammary artery (dotted arrow).
learly  visible  on  CT  scanning  (P  =  0.002)  and  a  large  tumor
ver 5  cm  in  size  (P  =  0.025).
ight renal artery
umors,  which  develop  in  the  postero-inferior  part  of  the
ight lobe  of  the  liver,  can  be  vascularized  by  a  superior  renal
apsular branch  in  up  to  2.2%  of  the  cases  [8].  The  supe-
ior renal  capsular  artery  arises  from  the  inferior  adrenal
rtery and  therefore,  it  is  sometimes  difﬁcult  to  distinguish
hese arteries  from  each  other  in  multifocal  hepatocellular
arcinoma. This  neovascularization  has  been  described  sec-
ndary to  surgery,  despite  the  hepatic  artery  being  patent
22].
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umbar arteries
ery  occasionally,  the  lumbar  arteries  can  provide  extra-
epatic ‘‘parasitic’’  vascularization  to  a  hepatocellular
arcinoma (from  0.1%  to  2%)  [8,23].  This  vascularization
ften occurs  at  a  late  stage  in  the  progression  of  the  malig-
ancy as  it  has  been  shown  to  occur  after  vascularization
and then  treatment)  [23]  by  the  right  inferior  phrenic
rtery.
typical post-treatment vascularization
ost-surgical neovascularization (branches of
he  GDA)
urgery,  either  resection  or  hepatectomy,  generally  divides
he hepatic  parietal  and  capsular  arteries.  Healing  results
n neovascularization  with  stimulation  of  VEGF  growth  fac-
ors, which  is  greater  following  laparotomy  than  after
aparoscopy in  small  animals  [24].  As  a  result,  arter-
es, which  are  not  initially  destined  for  the  liver,  can
upply some  hepatocellular  carcinomas,  particularly  recurr-
nces at  the  hepatectomy  margin  (Fig.  15)  or  after  liver
esection [25].  The  arteries  involved  may  be  branches  of  the
t
h
t
r
igure 15. 58-year-old woman with hepatocellular carcinoma in a heal
elapse at the hepatectomy margin. Several anarchic new arteries have 
odules of hepatocellular carcinoma. (a) Arteriography of the common h
epatic artery (CHA), dividing into the left branch of the proper hepatic 
nto the right gastro-epiploic artery (RGEA). Many small anarchic new 
upplying the liver resection margin. (b) Selective arteriography of a 
rrow) is located in a horizontal dividing branch of the gastro-duodenal a
‘anastomotic’’ (dashed arrow) artery is dilated.J.  Cazejust  et  al.
astro-duodenal  artery,  the  superior  mesenteric  and  the
ight inferior  phrenic  artery.
hanges to pre-existing arteries after
hemoembolization  [26]
hemoembolization  may  also  result  in  vascular  redistri-
ution. It  reduces  or  even  stops,  arterial  blood  ﬂow  to
he tumor,  in  particular  using  loaded  beads,  which  can
mbolize irreversibly  unlike  temporary  embolization  with
esorbable haemostatic  gelatin  particles,  which  are  used
n lipiodol  chemoembolization.  Complete  occlusion  of  the
epatic artery  was  only  achieved  in  4%  of  the  cases  in
hich extra-hepatic  vascularization  was  found  and  it  is  pos-
ible that  distal  peripheral  hepatic  infarctions  secondary
o chemoembolization  may  result  in  omental  or  peritoneal
dhesions and  therefore  lead  to  new  vascularization  via
hese adhesions  [8].  In  relapsed  disease,  the  tumor  is  usu-
lly vascularized  by  the  hepatic  artery  and  its  branches,  but
ay  occasionally  be  supplied  by  arteries  not  destined  for  the
iver. It  is  important  to  check  on  follow-up  imaging  sections
hat chemoembolization  has  not  altered  the  diameter  of  the
epatic arteries  (stenosis,  obstruction,  dissection,  etc.)  or
hat of  the  extra-hepatic  arteries  (increase  in  diameter  as  a
esult of  recruitment)  (Fig.  16).
thy liver. A right hepatectomy was performed 1 year before trifocal
developed in contact with the liver resection margin supplying the
epatic artery showing the catheter (dotted arrow) in the common
artery (L Br. PHA) and the gastro-duodenal artery, which continues
vessels (dashed arrows) arise from these arteries and intertwine,
branch of the gastro-duodenal artery. The microcatheter (dotted
rtery. The three tumor blushes are shown by the white arrows. The
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Figure 16. 73-year-old male patient with hepatocellular carcinoma in the right lobe of the liver treated by chemoembolization using
non-resorbable loaded particles (with doxorubicin). (a) Axial abdominal CT with MIP reconstruction performed before chemoembolization
showing a phrenic artery of normal diameter (arrow); the right and left branches of the hepatic artery are patent and of the same diameter.
(b) Axial abdominal CT with MIP after chemoembolization, showing recurrence of tumor in segment VII of the liver, and a phrenic artery
nt C
pared
[
[which is increased in diameter (arrow) compared to the pre-treatme
moderate hypertrophy of the left branch of the hepatic artery com
Conclusion
The  great  majority  of  hepatocellular  carcinomas  are  vas-
cularized from  the  hepatic  artery  and  its  branches.  Before
chemoembolization, the  hepatic  arterial  anatomy  must  be
checked and  it  is  vital  that  its  major  variants  are  recognised
on the  pre-treatment  CT  scan  or  arteriography.
These  tumors  may,  however,  acquire  atypical  ‘‘parasitic’’
vascularization from  extra-hepatic  arteries  recruited  by  the
tumor. There  are  some  recognized  risk  factors,  which  must
be looked  for:  a  past  history  of  resection,  hepatectomy  or
repeated chemoembolization  and  large  peripheral,  subcap-
sular, exophytic  tumors.  In  addition,  ﬁnding  a  large  diameter
extra-hepatic artery  running  towards  the  liver  or  a  vascular
pedicle belonging  to  the  tumor  itself  on  the  pre-treatment
CT scan  is  evidence  that  the  tumor  has  acquired  ‘‘parasitic’’
vascular supply.
All of  these  ﬁndings  should  be  noted  on  the  CT  or  MRI
report in  the  assessment  of  a  hepatocellular  carcinoma  and
must be  taken  into  account  by  the  interventional  radiologist
during chemoembolization.
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